Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Rafael Holdings, Inc.RFL · Entity 6620 | CHIEF MEDICAL OFFICER | January 13, 2025 | January 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Rafael Holdings, Inc.
Report date January 13, 2025 · Filed January 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common Stock, par value $.01 per shareSEC Table I · non-derivative | Direct | 50,000 |
Reported balance
After 2025-01-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-01-13 · Grant · Acquired 50,000 · Balance 50,000 F1: Grant of Restricted Stock that vests as follows: 12,500 shares on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029. F2: Consists of 50,000 shares of Restricted Stock that vests as follows: 12,500 on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Restricted Stock that vests as follows: 12,500 shares on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029.
F2: Consists of 50,000 shares of Restricted Stock that vests as follows: 12,500 on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 13, 2025 Filed Jan 15, 2025 19:22 UTC | Rafael Holdings, Inc. RFL · Entity 6620 | GrantClass B Common Stock, par value $.01 per share | 50,000 | $1.95 | $97,700.00 |
DisclosureSEC source: 0000950170-25-005760 · ownership.xml · nonDerivative · entry 1 GOLDBERG JOHN · CIK 0002007903 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · shares: Grant of Restricted Stock that vests as follows: 12,500 shares on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029. F2 · balance_after: Consists of 50,000 shares of Restricted Stock that vests as follows: 12,500 on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 14:23 UTC | Rafael Holdings, Inc. RFL · Entity 6620 | GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0000950170-24-005202 · ownership.xml · derivative · entry 1 GOLDBERG JOHN · CIK 0002007903 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Class B Common Stock · 250,000 shares Expires 2034-01-15 F1 · derivative.exercise_date: Option vests as follows: 62,500 on each of November 20, 2024, November 20, 2025, November 20, 2026 and November 20, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.